Ferran Fece de la Cruz

Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers

Aparna R. Parikh, Ignaty Leshchiner, Liudmila Elagina et al. · Nature Medicine · 2019 · 513 citations

Gastrointestinal Oncology, Tumor Heterogeneity, Medicine +11

TAS-120 Overcomes Resistance to ATP-Competitive FGFR Inhibitors in Patients with FGFR2 Fusion–Positive Intrahepatic Cholangiocarcinoma

Lipika Goyal, Lei Shi, Leah Y. Liu et al. · Cancer Discovery · 2019 · 363 citations · Full text

A reversible gene trap collection empowers haploid genetics in human cells

Tilmann Bürckstümmer, Carina Banning, Philipp Hainzl et al. · Nature Methods · 2013 · 108 citations · Full text

Human Cells, Genetics, Genomic Mechanism +6

Co-occurring Alterations in the RAS–MAPK Pathway Limit Response to MET Inhibitor Treatment in MET Exon 14 Skipping Mutation-Positive Lung Cancer

Julia Rotow, Philippe Gui, Wei Wu et al. · Clinical Cancer Research · 2019 · 102 citations · Full text

Landscape of Clinical Resistance Mechanisms to FGFR Inhibitors in FGFR2-Altered Cholangiocarcinoma

Qibiao Wu, Haley Ellis, Giulia Siravegna et al. · Clinical Cancer Research · 2023 · 68 citations · Full text